COMBINED TREATMENT OF ISONICOTINIC ACID HYDRAZIDE METHANSULFONATE AND SULFAMONOMETHOXINE FOR PULMONARY TUBERCULOSIS

スポンサーリンク

概要

• 論文の詳細を見る

• Retreatment cases of pulmonary tuberculosis 17 in number, were treated with isonicotinicacid hydrazide methansulfonate (IHMS) and sulfamonomethoxine for 4 months, and the clinicaleffects and side effects were observed.<BR>The appearance of INH-resistant tubercle bacilli was delayed by the combined use ofsulfamonomethoxine with IHMS as well as by other sulfa-drugs.<BR>From these results it is considered that combined therapy of IHMS and sulfamonomethoxineis advisable, and the therapentic value of sulfamonomethoxine is equal to that of the othersulfa-drugs already reported.

• 一般社団法人 日本結核病学会の論文

著者

• 栗村 武敏

  神戸市立玉津療養所

• 影浦 正輝

  神戸市立玉津病

• 伊藤 文雄

  大阪大学山村内科

関連論文

• 8) 慢性肺性心の症例(第2回日本循環器學會近畿地方學會總會)
• Rifampicin毎日と間欠治療症例の遠隔成績
• 再治療肺結核におけるRifampicin毎日と間欠療法の臨床効果の比較
• Clinical and Bacteriological Observations of Unclassified Acid-fast Bacilli Repeatedly Isorated During a Long Period of Time from Sputum of a Patient treated as Pulmonary Tuberculosis
• COMBINED TREATMENT OF ISONICOTINIC ACID HYDRAZIDE METHANSULFONATE AND SULFAMONOMETHOXINE FOR PULMONARY TUBERCULOSIS

スポンサーリンク